Press Releases Eli Lilly and Company Euronext Paris

Equities

LLY

US5324571083

Real-time Euronext Paris Other stock markets 11:05:35 2019-10-29 EDT			5-day change	1st Jan Change
98 ^EUR	-1.01%		-.--%	+2.08%

06-14	Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup	DJ
06-14	Investors need more time to assess Fed comments

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	06-08	PR
Lilly announces departure of Anat Ashkenazi, chief financial officer	06-05	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	06-05	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	06-04	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	06-03	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	05-31	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	05-29	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	05-29	AQ
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference	05-28	PR
Major manufacturing investment to support API production for tirzepatide	05-27	AQ
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro	05-24	AQ
Eli Lilly and : 2015 Global Health Programs Report	05-24	PU
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines	05-24	PR
Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise, Tuesday, 5/21/2024	05-21	AQ
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	05-21	AQ
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin	05-16	PR
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer	05-15	PR
Eli Lilly and : Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation	05-14	PU
Eli Lilly and : Lilly Statement on FDA Advisory Committee Meeting on Donanemab for Early Symptomatic Alzheimer’s Disease	05-07	PU
Lilly Declares Second-Quarter 2024 Dividend	05-06	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm